Regulation of plasminogen activator inhibitor-1 and urokinase by hyaluronan fragments in mouse macrophages

被引:64
作者
Horton, MR
Olman, MA
Bao, C
White, KE
Choi, AMK
Chin, BY
Noble, PW
Lowenstein, CJ
机构
[1] Yale Univ, Sch Med, Dept Vet Affairs Connecticut Healthcare Syst, Pulm Sect 111A,Dept Internal Med, West Haven, CT 06516 USA
[2] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21287 USA
[3] Univ Alabama Birmingham, Sch Med, Dept Med, Birmingham, AL 35294 USA
[4] Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06520 USA
关键词
extracellular matrix; lung; chronic fibrosis;
D O I
10.1152/ajplung.2000.279.4.L707
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
Pulmonary inflammation and fibrosis are characterized by increased turnover and production of the extracellular matrix as well as an impairment of lung fibrinolytic activity. Although fragments of the extracellular matrix component hyaluronan induce macrophage production of inflammatory mediators, the effect of hyaluronan on the fibrinolytic mediators plasminogen activator inhibitor (PAI)-1 and urokinase-type plasminogen activator (uPA) is unknown. This study demonstrates that hyaluronan fragments augment steady-state mRNA, protein, and inhibitory activity of PAI-1 as well as diminish the baseline levels of uPA mRNA and inhibit uPA activity in an alveolar macrophage cell line. Hyaluronan fragments alter macrophage expression of PAI-1 and uPA at the level of gene transcription. Similarly, hyaluronan fragments augment PAI-1 and diminish uPA mRNA levels in freshly isolated inflammatory alveolar macrophages from bleomycin-treated rats. These data suggest that hyaluronan fragments influence alveolar macrophage expression of PAI-1 and uPA and may be a mechanism for regulating fibrinolytic activity during lung inflammation.
引用
收藏
页码:L707 / L715
页数:9
相关论文
共 62 条
[1]   HYALURONIC ACID IN SYNOVIAL FLUID .I. MOLECULAR PARAMETERS OF HYALURONIC ACID IN NORMAL AND ARTHRITIC HUMAN FLUIDS [J].
BALAZS, EA ;
WATSON, D ;
DUFF, IF ;
ROSEMAN, S .
ARTHRITIS AND RHEUMATISM, 1967, 10 (04) :357-&
[2]   Plasminogen activator inhibitor-1 in acute hyperoxic mouse lung injury [J].
Barazzone, C ;
Belin, D ;
Piguet, PF ;
Vassalli, JD ;
Sappino, AP .
JOURNAL OF CLINICAL INVESTIGATION, 1996, 98 (12) :2666-2673
[3]   DEPRESSED BRONCHOALVEOLAR UROKINASE ACTIVITY IN PATIENTS WITH ADULT RESPIRATORY-DISTRESS SYNDROME [J].
BERTOZZI, P ;
ASTEDT, B ;
ZENZIUS, L ;
LYNCH, K ;
LEMAIRE, F ;
ZAPOL, W ;
CHAPMAN, HA .
NEW ENGLAND JOURNAL OF MEDICINE, 1990, 322 (13) :890-897
[4]   MECHANISMS OF PULMONARY FIBROSIS - SPONTANEOUS RELEASE OF THE ALVEOLAR MACROPHAGE-DERIVED GROWTH-FACTOR IN THE INTERSTITIAL LUNG DISORDERS [J].
BITTERMAN, PB ;
ADELBERG, S ;
CRYSTAL, RG .
JOURNAL OF CLINICAL INVESTIGATION, 1983, 72 (05) :1801-1813
[5]  
Blasi F, 1990, Semin Cancer Biol, V1, P117
[6]  
BONIFACINO JS, 1991, CURRENT PROTOCOLS MO
[7]  
BOWDEN DH, 1984, LAB INVEST, V50, P487
[8]   PLASMINOGEN-ACTIVATOR INHIBITOR-1 GENE DEFICIENT MICE .2. EFFECTS ON HEMOSTASIS, THROMBOSIS, AND THROMBOLYSIS [J].
CARMELIET, P ;
STASSEN, JM ;
SCHOONJANS, L ;
REAM, B ;
VANDENOORD, JJ ;
DEMOL, M ;
MULLIGAN, RC ;
COLLEN, D .
JOURNAL OF CLINICAL INVESTIGATION, 1993, 92 (06) :2756-2760
[9]  
CHAPMAN HA, 1990, J IMMUNOL, V145, P3398
[10]  
CLARK RAF, 1988, J BIOL CHEM, V263, P12115